The Lancet Gastroenterology & Hepatology· Wesam Aleyadeh, Marcelo Cypel, S Joseph Kim, Michael A McDonald, Jeffrey Schiff, Ana Carolina Alba, Shaf Keshavjee, Kaijo Yacht, Dipika Munyal, Rhonda Allan, June Wang, Deepali Kumar, Atul Humar, Jordan J Feld·· 2026-09-30AI 评分51
多器官移植受者使用多伦多HCV预防方案:一项回顾性匹配队列研究
[Articles] Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study
AI 导读
多伦多HCV预防方案在非肝移植受者中有效预防或快速清除HCV感染,且总体生存率与HCV阴性对照组无差异。该短疗程方案提供了一种成本较低的替代标准抗病毒治疗方案,支持使用HCV阳性供体器官。
来源:The Lancet Gastroenterology & Hepatology · thelancet.com